Orasure Technologies EV/EBIT OSUR

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2014.

Today, Oct 23, 2026: n/m; an operating loss
Last meaningful: 3.0×; Nov 2024
10-year median: 23.0×
10-year range: 0.2× to 77.0×
Peer median: 14.6×

Orasure Technologies has no meaningful EV/EBIT today: it made an operating loss of $54M over the last twelve months.

It was last meaningful in Nov 2024, at 3.0×.

On the days it had one over the last ten years, its median was 23.0×, from 0.2× in Feb 2020 to 77.0× in Nov 2021.

EV/EBIT over time

median 23×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2024	3.0×	2.4×	7.9×
2023	7.2×	4.6×	8.5×
2022	57.7×	56.6×	68.6×
2021	64.2×	22.5×	77.0×
2020	65.2×	0.2×	65.2×
2019	0.3×	0.2×	25.0×
2018	21.0×	19.0×	46.9×
2017	39.9×	20.6×	50.2×
2016	21.4×	19.9×	203×
2015	182×	79.1×	495×
2014	125×	103×	479×

Against its peers

Companies in Medical - Instruments & Supplies nearest Orasure Technologies' size, closest first, today.

Company	EV/EBIT
OSUROrasure Technologies	n/m
INFUInfuSystem	22.4×
UTMDUtah Medical Products	6.0×
EMBCEmbecta	6.7×
PDEXPro DEX	16.0×
TCMDTactile Systems Technology	13.3×
MDXGMimedx	51.6×
MOVMovado	11.8×
KEQUKewaunee Scientific	7.2×
IRMDIradimed	37.7×
STAAStaar Surgical	57.7×
Peer median	14.6×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Orasure Technologies

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.